GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Gross-Profit-to-Asset %

Cantourage Group SE (XTER:HIGH) Gross-Profit-to-Asset % : 103.01% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cantourage Group SE's annualized Gross Profit for the quarter that ended in Dec. 2023 was €45.92 Mil. Cantourage Group SE's average Total Assets over the quarter that ended in Dec. 2023 was €44.57 Mil. Therefore, Cantourage Group SE's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 103.01%.

Cantourage Group SE Gross-Profit-to-Asset % Historical Data

The historical data trend for Cantourage Group SE's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE Gross-Profit-to-Asset % Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- 7.18 55.17 2.43 16.66

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial - - 2.69 2.67 103.01

Competitive Comparison of Cantourage Group SE's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantourage Group SE's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Gross-Profit-to-Asset % falls into.


Cantourage Group SE Gross-Profit-to-Asset % Calculation

Cantourage Group SE's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=7.41/( (44.785+44.178)/ 2 )
=7.41/44.4815
=16.66 %

Cantourage Group SE's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=45.916/( (44.971+44.178)/ 2 )
=45.916/44.5745
=103.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Cantourage Group SE Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantourage Group SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
Traded in Other Exchanges
HIGH:Germany
Address
Feurigstrasse 54, Berlin, DEU, 10827
Website
https://www.cantourage.com
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE Headlines